Clinical Trials Logo

Clinical Trial Summary

A prospective randomized cohort study to compare whether the placement of a double-pigtail plastic stent (DPS) within a lumen-apposing metal stent (LAMS) may improve the efficacy and safety of endoscopic ultrasound guided transmural drainage of walled-off pancreatic necrosis (WON) and thus prevent potential adverse events related to LAMS insertion.


Clinical Trial Description

The aim of the study is to compare endoscopic ultrasound guided transmural drainage using lumen-apposing metal stent with (1.) or without (2.) coaxial plastic stent in the management of walled-off pancreatic necrosis. The usage of LAMS has been evaluated as a safe and effective method for the drainage of walled-off pancreatic necrosis in various studies. However, complications such as bleeding, infection due to stent obstruction, stent migration, or buried stent syndrome have been reported. A preventive measure to minimize adverse events related to LAMS insertion by means of placing an anchoring DPS through the LAMS have been suggested but there has been no prospective randomized study to assess the utility of such measure to date. The study is to be conducted at a tertiary institution with an expertise in treating hepato-pancreato-biliary diseases. The main timeframe of the study is 3 weeks following LAMS insertion with or without DPS. All LAMS will be extracted 3 weeks after the initial procedure. The extraction will be preceded by a CT scan of the abdomen to assess whether the DPS needs to be left in place/ inserted in patients with incomplete resolution of the collection. In addition, material from the collection will be collected for cultivation at every endoscopic intervention to assess colonization by microbial flora over time. All patients will be closely followed with clinical, laboratory, and radiological assessment for 12 months in total. Our experience has shown failure of the (2.) method in 70 % of patients so far. Assuming a clinically significant difference to be a reduction to 40 % in failed patients using the (1) method, the required study population size was calculated to 62 patients (31 in both arms) by power analysis (at standard alpha and beta values). The final number was set to 70 as a safety measure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03923686
Study type Interventional
Source Palacky University
Contact
Status Completed
Phase N/A
Start date May 13, 2019
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT00061269 - Videoendoscopic Drainage of Infected Pancreatic Collections N/A
Recruiting NCT05530772 - Immediate vs. On-demand Endoscopic Necrosectomy in Infected Walled-off Pancreatic Necrosis N/A
Not yet recruiting NCT00508729 - Effect of Traditional Chinese Medicine on GI Function Recovery and Nutrition Support in SAP Phase 2/Phase 3
Recruiting NCT00506337 - Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis Phase 2/Phase 3
Recruiting NCT05601687 - Endoscopic Step-up Approach vs Aggressive Debridement of Large Pancreatic Walled-off Necrosis N/A
Completed NCT02473406 - Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis Phase 4
Recruiting NCT05451901 - Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis N/A
Recruiting NCT04443595 - Dual-scopic Pancreatic Necrosectomy (DPN) N/A
Not yet recruiting NCT06134024 - The Role of Double Pigtail Plastic Stents During Endoscopic Transmural Drainage of Pancreatic Fluid Collections. N/A
Not yet recruiting NCT02691598 - Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following Severe Acute Pancreatitis Phase 4
Completed NCT00061438 - A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died Phase 4
Completed NCT03643900 - The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis N/A
Terminated NCT03245619 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults Phase 1
Recruiting NCT02133014 - The Study of Laparoscopic-assisted Percutaneous Catheter-directed Drainage to Treat Early Severe Acute Pancreatitis N/A